![Zacks Market Edge show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/086/227/small/zacks-market-edge.jpg)
Summary: The Biotech stocks have been on a big run in 2017 but that doesn’t mean there aren’t some healthcare values still out there. Please pick a time stamped topic below: (0:45) - Emerging Biotech Market: Is It Time To Invest? (6:10) - Is Large Cap Biotech a Value Trap: Gilead, Biogen and Bluebird (12:00) - Generic Drug Companies: Teva, Valeant and AbbVie (15:50) - Managed Healthcare Sector: The Effects Of Obamacare (20:40) - Growth Stocks In Healthcare (23:30) - Healthcare Value Stock Screener (25:00) - Episode Roundup: Podcast@Zacks.com